Louse Borne Relapsing Fever

Also known as epidemic relapsing fever, this disease is caused by the spirochete bacterium Borrelia recurrentis. This pathogen is transmitted to humans by the human body louse, as first demonstrated by Sergent and Foley in 1910. Clinical symptoms include the sudden onset of fever, headache, muscle ache, anorexia, dizziness, nausea, coughing, and vomiting. Thrombocytopenia (a decrease in blood platelets) also can occur and cause bleeding, which may initially be confused for a symptom of a hemorrhagic fever. Episodes of fever last 2—12 days (average, 4 days), typically followed by periods of 2—8 days (average, 4 days) without fever, with two to five relapses being usual. As the disease progresses, the liver and spleen enlarge rapidly, leading to abdominal discomfort and labored, painful breathing as the lungs and diaphragm are compressed. At this stage, most patients remain quietly prostrate with a glazed expression, often shivering and taking shallow breaths. Mortality rates for untreated outbreaks range from 5 to 40%. Antibiotic treatment is with penicillin or tetracycline. Humans are the sole known reservoir of B. recurrentis.

Body lice become infected when they feed on an infected person with circulating spirochetes. Most of the spirochetes perish when they reach the louse gut, but a few survive to penetrate the gut wall, where they multiply to massive populations in the louse hemolymph, nerves, and muscle tissue. Spirochetes do not invade the salivary glands or ovarian tissues and are not voided in louse feces. Therefore, transmission to humans occurs only when infected lice are crushed during scratching, which allows the spirochetes in infectious hemolymph to invade the body through abrasions and other skin lesions. However, B. recurrentis is also capable of penetrating intact skin. As with R. prowazekii infections, body lice are killed as a result of infection with B. recurrentis.

An intriguing history of human epidemics of louse-borne relapsing fever is provided by Bryceson et al. (1970). Hippocrates described an epidemic of "caucus," or "ardent fever," in Thasos, Greece, which can clearly be identified by its clinical symptoms as this malady. During 1727—1729, an outbreak in England killed all inhabitants of many villages. During the present century, an epidemic that spread from eastern Europe into Russia during 1919—1923 resulted in 13 million cases and 5 million deaths. Millions also were infected during an epidemic that swept across North Africa in the 1920s. Several major epidemics subsequently have occurred in Africa, with up to 100,000 fatalities being recorded for some of them. During and immediately after World War II, more than a million persons were infected in Europe alone.

The only current epidemic of louse-borne relapsing fever is in Ethiopia, where 1000—5000 cases are reported annually, accounting for ca. 95% of the world's recorded infections. Other smaller foci occur intermittently in other regions, such as Burundi, Rwanda, Sudan, Uganda, People's Republic of China, the Balkans, Central America, and the Peruvian Andes. Resurgence of this disease under conditions of warfare or famine is an ominous possibility. Additional information on louse-borne relapsing fever is provided by Bryceson et al. (1970).

Trench Fever

Also known as five-day fever and wolhynia, trench fever is caused by infection with the bacterium Bartonella (formerly Rochalimaea) quintana. Like the two preceding diseases, the agent is transmitted by the human body louse. Human infections range from asymptomatic through mild to severe, although fatal cases are rare. Clinical symptoms are nonspecific and include headache, muscle aches, fever, and nausea. The disease can be cyclic, with several relapses often occurring. Previously infected persons often maintain a cryptic infection which can cause relapses years later, with the potential for spread to other persons if they are infested with body lice. Effective antibiotic treatment of patients involves administering drugs such as doxycycline or tetracycline.

Lice become infected with B. quintana after feeding on the blood of an infected person. The pathogen multiplies in the lumen of the louse midgut and in the cuticular margins of the midgut epithelial cells. Viable rickettsiae are voided in louse feces, and transmission to humans occurs by the posterior-station route when louse bites are scratched. B. quintana can remain infective in dried louse feces for several months, contributing to aerosol transmission as an alternative route of transmission. Transovarial transmission does not occur in the louse vector. Infection is not detrimental to lice and does not affect their longevity.

Trench fever was first recognized as a clinical entity in 1916 as an infection of European troops engaging in trench warfare during World War I. At that time, more than 200,000 cases were recorded in British troops alone. Between the two world wars, trench fever declined in importance but re-emerged in epidemic proportions in troops stationed in Europe during World War II. Because of the presence of asymptomatic human infections, the current distribution of trench fever is difficult to determine. However, since World War II, infections have been recorded in several European and African nations, Japan, the People's Republic of China, Mexico, Bolivia, and Canada.

Until recently, B. quintana was considered to be transmitted solely by body lice. However, several homeless or immunocompromised people, including HIV-positive individuals, particularly in North America and Europe, have presented with opportunistic B. quintana infections. This is manifested not as trench fever but as vascular tissue lesions, liver pathology, chronically swollen lymph nodes, and inflammation of the lining of the heart. Because some of these patients were not infested by body lice, an alternate mode of pathogen transmission may have been involved.

Allergy Relief

Allergy Relief

Have you ever wondered how to fight allergies? Here are some useful information on allergies and how to relief its effects. This is the most comprehensive report on allergy relief you will ever read.

Get My Free Ebook


Post a comment